14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

Trading levels for CRIS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 17.46 5.75 %
R2 17.10 3.57 %
R1 16.88 2.22 %
Current price: 16.51
Support S1 16.15 -2.16 %
S2 15.93 -3.51 %
S3 15.57 -5.69 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 16.80 1.76 %
Current price 16.51
Support S1 16.01 -3.03%
S2 15.58 -5.63%
S3 12.68 -23.20%

CRIS Predictions History

3 years ago
Jack BrooksVlogs predicted that CRIS for 2021-02-17 is going

Rank:

3 years ago
N B predicted that CRIS for 2021-02-17 is going

Rank:

3 years ago
Aaron Morris predicted that CRIS for 2021-02-17 is going

Rank:

3 years ago
Chandrashaker Akula predicted that CRIS for 2021-02-17 is going

Rank:

3 years ago
Dexter Hunt predicted that CRIS for 2021-02-17 is going

Rank:

3 years ago
Ernesto Bernal predicted that CRIS for 2021-02-17 is going

Rank:

3 years ago
Bakecoat predicted that CRIS for 2021-02-17 is going $40.00 (278.43%)

Rank:

3 years ago
satvik123 predicted that CRIS for 2021-02-17 is going

Rank:

3 years ago
Elmore Lowery predicted that CRIS for 2021-02-17 is going

Rank:

3 years ago
Chamaine (Sweet Gibraltar Weddings) predicted that CRIS for 2021-02-17 is going

Rank:
Click to get the best stock tips daily for free!

About Curis

Curis Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myeloid leukemia and myelodysplastic syndromes; and CI-8993, a monoclonal antibody designed to antagonize t... CRIS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT